- The Effects of Systemic Psoriasis Therapies on the C-Reactive Protein and the Neutrophil-Lymphocyte Ratio
-
Aktaş Karabay E, Aksu Çerman A, Demir D, Kıvanç Altunay I
- KMID: 2461982
- Ann Dermatol.
- 2019 Dec;31(6):601-610.
- doi: 10.5021/ad.2019.31.6.601
BACKGROUND: Currently, no generally accepted laboratory marker for monitorizing the disease activity and therapy response of psoriasis is known. OBJECTIVE: The aim of the study is to evaluate the effects of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
-
Lee S, Park YJ, Lee JY
- KMID: 2461174
- J Korean Med Sci.
- 2019 Nov;34(42):e278.
- doi: 10.3346/jkms.2019.34.e278
BACKGROUND: Tumor necrosis factor-alpha (TNF-α) inhibitors (TNFis), which are the main treatment for ankylosing spondylitis (AS), have been reported not only to reduce the incidence of anterior uveitis (AU) but... -
- CITED
-
- Close
- SHARE
-
- Close
- Pustulotic Arthro-osteitis Improved with Anti TNF-α Inhibitor
-
Park HS, Kim JH, Kim HW, Kim SC
- KMID: 2457688
- Korean J Dermatol.
- 2019 Aug;57(7):378-382.
Pustulotic arthro-osteitis (PAO) is a rare chronic inflammatory disorder characterized by inflammatory osteitis of the sternoclavicular joint and palmoplantar pustulosis. Here, we report a case of PAO that was successfully... -
- CITED
-
- Close
- SHARE
-
- Close
- Long Term Safety and Efficacy of Etanercept in Juvenile Idiopathic Arthritis in a Single Center
-
Bang MH, Kim KN
- KMID: 2451512
- J Rheum Dis.
- 2019 Jul;26(3):200-205.
- doi: 10.4078/jrd.2019.26.3.200
OBJECTIVE: Our aim was to investigate the long term safety and efficacy of etanercept in children with juvenile idiopathic arthritis (JIA). METHODS: The study subjects were the 90 JIA patients treated... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Experience with Etanercept Therapy and the Switching Pattern among Korean Patients with Psoriasis after Withdrawal of Etanercept
-
Choi CW, Lee JS, Yu DA, Kim BR, Youn SW
- KMID: 2430800
- Ann Dermatol.
- 2019 Feb;31(1):44-50.
- doi: 10.5021/ad.2019.31.1.44
BACKGROUND: The efficacy and safety of etanercept in the treatment of psoriasis has been proven, and the drug was approved for the treatment of moderate to severe psoriasis. However, there... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease
-
Park J, Cheon JH
- KMID: 2427452
- Gut Liver.
- 2018 Nov;12(6):623-632.
- doi: 10.5009/gnl17462
Intestinal Behçet's disease is a rare, immune-mediated chronic intestinal inflammatory disease; therefore, clinical trials to optimize the management and treatment of patients are scarce. Moreover, intestinal Behçet's disease is difficult... -
- CITED
-
- Close
- SHARE
-
- Close
- IgA nephropathy in a patient with ankylosing spondylitis well controlled with etanercept
-
Lee DH, Kim GT, Hwang NK, Kim EH
- KMID: 2415843
- Kosin Med J.
- 2018 Jun;33(1):85-90.
- doi: 10.7180/kmj.2018.33.1.85
Ankylosing spondylitis (AS) can involve the eye, gastrointestinal system, cardiopulmonary system, skin, kidneys, and spinal and peripheral joints. It is rarely accompanied by immunoglobulin A (IgA) nephropathy. Although IgA is... -
- CITED
-
- Close
- SHARE
-
- Close
- Transaminase Changes in Korean Rheumatoid Arthritis Patients with Chronic Hepatitis C after Biologic Therapy
-
Kwon HM, Shin K, Moon JY, Lee SS, Chung WT, Lee J, Lee SH, Kang SW, Suh CH, Hong SJ, Song R, Choe JY, Song YW
- KMID: 2408928
- J Rheum Dis.
- 2018 Apr;25(2):108-115.
- doi: 10.4078/jrd.2018.25.2.108
OBJECTIVE: Coexisting chronic hepatitis C can be problematic when treating rheumatoid arthritis (RA). This study examined the changes in the transaminase and viral load in hepatitis C virus (HCV)-infected RA... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea
-
Jeong H, Eun YH, Kim IY, Kim H, Ahn JK, Lee J, Koh EM, Cha HS
- KMID: 2411553
- Korean J Intern Med.
- 2018 Mar;33(2):407-416.
- doi: 10.3904/kjim.2016.042
BACKGROUND/AIMS: To evaluate drug survival of the tumor necrosis factor α inhibitors (TNFi) and risk factors for the drug discontinuation in patients with ankylosing spondylitis (AS). METHODS: We retrospectively evaluated 487... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Undergoing Biologic Disease-Modifying Therapy
-
Kwon HM, Lee SJ, Yang JA, Choi Y, Park JK, Lee EY, Song YW, Lee EB
- KMID: 2389063
- J Rheum Dis.
- 2017 Aug;24(4):220-226.
- doi: 10.4078/jrd.2017.24.4.220
OBJECTIVE: Rheumatoid arthritis (RA) patients suffer from an increased risk of herpes zoster (HZ) partially due to immunosuppressant medications. This study investigated HZ in RA patients treated with biologic disease-modifying... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative efficacy of biological agents in methotrexate-refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison
-
Choi M, Hyun MK, Choi S, Tchoe HJ, Lee SY, Son KM, Kim MJ, Jung YO, Kim HA
- KMID: 2379485
- Korean J Intern Med.
- 2017 May;32(3):536-547.
- doi: 10.3904/kjim.2015.135
BACKGROUND/AIMS: Biological agents (biologics) targeting proinflammatory signaling have emerged as an important treatment option in rheumatoid arthritis (RA). Despite the clinical effectiveness of biologics for patients with RA who do... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature
-
Park SK, Hwang PH, Yun SK, Kim HU, Park J
- KMID: 2368031
- Ann Dermatol.
- 2017 Feb;29(1):74-78.
- doi: 10.5021/ad.2017.29.1.74
The development of cutaneous sarcoidosis as a paradoxical adverse event of tumor necrosis factor alpha (TNF-α) blockers has been reported in the literature; however, an erythrodermic form of cutaneous sarcoidosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Necrosis Factor Blockade Stimulates Circulating Osteoblastic Lineage Cells Activity while Reducing Circulating Osteoclasts
-
Lim MJ, Kwon SR, Jung KH, Park W
- KMID: 2364689
- J Rheum Dis.
- 2016 Dec;23(6):356-362.
- doi: 10.4078/jrd.2016.23.6.356
OBJECTIVE: This study examines the effects of tumor necrosis factor (TNF) blockade on markers of bone metabolism in peripheral blood from active rheumatoid arthritis (RA) patients. METHODS: Eighteen patients (16 women,... -
- CITED
-
- Close
- SHARE
-
- Close
- Recurrent macrophage activation syndrome since toddler age in an adolescent boy with HLA B27 positive juvenile ankylosing spondylitis
-
Park JH, Seo YM, Han SB, Kim KH, Rhim JW, Chung NG, Kim MS, Kang JH, Jeong DC
- KMID: 2355571
- Korean J Pediatr.
- 2016 Oct;59(10):421-424.
- doi: 10.3345/kjp.2016.59.10.421
Recurrent macrophage activation syndrome (MAS) is very rare. We present the case of an adolescent boy with human leukocyte antigen (HLA) B27-positive ankylosing spondylitis (AS), who experienced episodes of recurrent... -
- CITED
-
- Close
- SHARE
-
- Close
- Dose Optimization for Single Intradiscal Administration of the Tumor Necrosis Factor-α Inhibitor, Etanercept, in Rat Disc Injury Models
-
Inage K, Orita S, Yamauchi K, Suzuki T, Suzuki M, Sakuma Y, Kubota G, Oikawa Y, Sainoh T, Sato J, Fujimoto K, Shiga Y, Abe K, Kanamoto H, Inoue M, Kinoshita , Takahashi , Ohtori S
- KMID: 2349282
- Asian Spine J.
- 2016 Aug;10(4):619-623.
- doi: 10.4184/asj.2016.10.4.619
STUDY DESIGN: Experimental animal study. PURPOSE: We aimed to determine the optimal dose of a single direct injection of the tumor necrosis factor (TNF)-α inhibitor, etanercept, by using the rat model... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Sarcoidosis That Improved upon Discontinuation of Etanercept
-
Kang JH, Ahn JH, Yu JE, Kim JE, Yim YR, Lee JW, Lee KE, Park DJ, Wen L, Park YW, Lee SS
- KMID: 2326735
- J Rheum Dis.
- 2016 Jun;23(3):187-192.
- doi: 10.4078/jrd.2016.23.3.187
A 31-year-old man who had been prescribed etanercept over a 3-year period for treatment of ankylosing spondylitis presented with newly developed dry cough, chills, myalgia, and weight loss. Chest computed... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-Minimization Analysis of Biologic Disease-Modifying Antirheumatic Drugs Administered by Subcutaneous Injections in Patients with Rheumatoid Arthritis
-
Park SH, Lee MY, Lee EK
- KMID: 2226432
- Korean J Clin Pharm.
- 2016 Mar;26(1):59-69.
- doi: 10.0000/kjcp.2016.26.1.59
BACKGROUND: The subcutaneous formulation of biologic disease-modifying antirheumatic drugs (DMARDs) was preferred due to favored self-administration and would be an economical treatment option for patients with rheumatoid arthritis. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Drug Utilization for Patients with Ankylosing Spondylitis
-
Kang HB, Je NK
- KMID: 2226418
- Korean J Clin Pharm.
- 2015 Dec;25(4):246-253.
- doi: 10.0000/kjcp.2015.25.4.246
BACKGROUND & OBJECT: Ankylosing spondylitis (AS) is a chronic inflammatory disease that causes ankylosis and deformation of axial joints. Since current medicine cannot cure the disease yet, alleviating pain and... -
- CITED
-
- Close
- SHARE
-
- Close
- The Incidence of Uveitis in Ankylosing Spondylitis Patients Undergoing Tumor Necrosis Factor Inhibiting Therapy in Korea
-
Koo BS, Hong S, Kim YJ, Lee CK, Yoo B, Kim YG
- KMID: 2222840
- J Rheum Dis.
- 2015 Oct;22(5):288-292.
- doi: 10.4078/jrd.2015.22.5.288
OBJECTIVE: The purpose of this study is to evaluate the outcome of uveitis in ankylosing spondylitis (AS) during tumor necrosis factor (TNF)-inhibiting therapy and to compare the incidence rate of... -
- CITED
-
- Close
- SHARE
-
- Close
- The use of biologics for severe psoriasis
-
Youn SW
- KMID: 2195107
- J Korean Med Assoc.
- 2015 Oct;58(10):917-922.
- doi: 10.5124/jkma.2015.58.10.917
Psoriasis is a life-long chronic relapsing dermatosis that shows waxing and waning of disease despite of a lot of conventional treatment. Severe psoriasis, usually defined by a psoriasis area and... -
- CITED
-
- Close
- SHARE
-
- Close
